A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients
Clinical trial NCT00488059 · TERMINATED
Trial details
- NCT number
- NCT00488059
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2008-10-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.